Moderna (MRNA) Completes Submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine
Go back to Moderna (MRNA) Completes Submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 145.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.55 | 52 Week High | $0.52 | |||
| Open | $145.55 | 52 Week Low | $0.08 | |||
| Day High | $145.55 | P/E | N/A | |||
| Day Low | $145.55 | EPS | $-3.80 | |||
| Volume | 144,361 | |||||
